Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS
Official title: Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS: An Ambispective Cohort Study
Run by Air Force Military Medical University, China · NCT07799948 · Data updated 2026-11-12
A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Air Force Military Medical University, China Academic / other |
| Locations | 1 site (Xi'an, Shaanxi) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 2, 2026 |
| Trial ID | NCT07799948 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a prior TIPS who have recurrent grade II or higher hepatic encephalopathy despite optimized medical therapy.
✕Probably not a fit
Patients without recurrent HE or without suitable anatomy for stent-based flow reduction may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center ambispective study evaluating a coil-anchored, small-diameter covered-stent approach to reduce shunt flow after TIPS in patients with refractory hepatic encephalopathy. The method uses coils as an anchor inside the TIPS tract, followed by placement of a 6-mm covered stent to achieve controlled flow reduction. The study aims to assess both safety and efficacy, comparing outcomes in patients who receive the intervention to historical controls or retrospective data. Standard medical therapies remain the baseline for all participants, with the intervention added for those with persistent HE. Results will inform whether this technique can provide more precise shunt flow control and improve HE-related outcomes.
Why it matters
Potential benefit: If successful, patients may experience fewer HE episodes and improved quality of life due to better-controlled shunt flow.
How similar studies have gone: Shunt reduction to manage HE after TIPS has been explored, with variable success; this coil-assisted approach represents a more controlled technique.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria 1. Prior transjugular intrahepatic portosystemic shunt (TIPS) placement; 2. Confirmation of patent TIPS stent via imaging and/or hemodynamic evaluation; 3. Recurrent episodes of grade II or higher hepatic encephalopathy (by West-Haven criteria) occurring more than twice within a 4-week period, despite standard medical therapy including lactulose, rifaximin, nutritional support, and correction of precipitating factors; 4. Treatment with coil-assisted small-diameter stent shunt reduction; 5. Signed informed consent provided by the patient or legal representative (for the prospective cohort). Exclusion Criteria 1. Presence of severe extrahepatic organ failure (e.g., cardiac, pulmonary, or renal failure); 2. Significant missing data that precludes evaluation in the retrospective cohort.
Where it's running
-
Air Force Military Medical University
Xi'an, Shaanxi, China Recruiting
Study contacts
- Principal investigator: Jun Tie — Air Force Military Medical University, China
- Study coordinator: Jun Tie, M.D.,Ph.D
- Email: tiejun7776@163.com
- Phone: +862984771537
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observational study on advanced chronic liver diseases in Vienna
This study looks at patients with advanced chronic liver diseases in Vienna to see how their condition affects blood pressure in the liver and to collect samples for future research.
-
Austrian PBC Registry
This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.
-
Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis
This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.
-
Blood clotting and portal vein changes during TIPS placement in cirrhosis
This project will see how blood clotting in the body and in the portal vein changes in adults with cirrhosis who are having a TIPS placed.
-
Developing and testing the Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
This project will test a short questionnaire called LiCCoS to see if it can spot thinking and everyday mental problems in adults with liver cirrhosis.
-
Handgrip strength and portal vein blood flow in people with liver cirrhosis
This trial will test whether squeezing a handgrip changes portal vein and left gastric vein pressures and blood flow in adults with liver cirrhosis to see if muscle strength affects variceal hemodynamics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.